<code id='49F944DF5B'></code><style id='49F944DF5B'></style>
    • <acronym id='49F944DF5B'></acronym>
      <center id='49F944DF5B'><center id='49F944DF5B'><tfoot id='49F944DF5B'></tfoot></center><abbr id='49F944DF5B'><dir id='49F944DF5B'><tfoot id='49F944DF5B'></tfoot><noframes id='49F944DF5B'>

    • <optgroup id='49F944DF5B'><strike id='49F944DF5B'><sup id='49F944DF5B'></sup></strike><code id='49F944DF5B'></code></optgroup>
        1. <b id='49F944DF5B'><label id='49F944DF5B'><select id='49F944DF5B'><dt id='49F944DF5B'><span id='49F944DF5B'></span></dt></select></label></b><u id='49F944DF5B'></u>
          <i id='49F944DF5B'><strike id='49F944DF5B'><tt id='49F944DF5B'><pre id='49F944DF5B'></pre></tt></strike></i>

          hotspot

          hotspot

          author:explore    Page View:67256
          Trump Campaign Event In Nevada
          Ethan Miller/Getty Images

          WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.

          In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.

          advertisement

          “Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more
          Asahi Kasei to buy Calliditas, picking up kidney disease drug
          Asahi Kasei to buy Calliditas, picking up kidney disease drug

          AdobeLONDON—Seekingtobuildupitspharmabusiness,theJapaneseconglomerateAsahiKaseiismovingtobuySwedishb

          read more
          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more

          Ventyx halts psoriasis drug development after lackluster trial results

          AdobeSANDIEGO—VentyxBiosciencesreportedonMondaythatitwasendingdevelopmentofanexperimentaldrugfortrea